CTOs on the Move

Source! Nutrition

www.sourcenutrition.com

 
Source! Nutrition is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Perception Health

With more than 26 billion medical claims and 7 million more added every day, we have the industry`s strongest and fastest growing data framework. Add the simple, at-a-glance visuals, and the personalized expertise from our data scientists and you have a full spectrum of tools that help validate strategies and optimize workflows that benefit providers, payers, and patients across your entire system.

Cariten Healthcare

Cariten Healthcare is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Georgetown Health Care Ctr

Georgetown Health Care Ctr is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AbCRO

AbCRO is a Stamford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fresenius Kabi

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.